![Bortezomib sensitizes thyroid cancer to BRAF inhibitor
<i>in vitro</i>
and
<i>in vivo</i>]()
Bortezomib sensitizes thyroid cancer to BRAF inhibitor
<i>in vitro</i>
and
<i>in vivo</i>Tsumagari, Koji; Abd Elmageed, Zakaria Y; Sholl, Andrew B; Green, Erik A; Sobti, Saboori; Khan, Abdul Razzaq; Kandil, Abdulrahman; Murad, Fadi; Friedlander, Paul; Boulares, A Hamid; Kandil, Emad · Endocrine-Related Cancer · 2018